Literature DB >> 14585523

Menopausal status, hormone replacement therapy use and risk of self-reported physician-diagnosed osteoarthritis in women attending menopause clinics in Italy.

Fabio Parazzini1.   

Abstract

OBJECTIVE: In order to offer data on the association between menopausal status, hormone replacement therapy use and risk of self-reported physician-diagnosed osteoarthritis (OA) in women around menopause, we analyzed information collected in the framework of a large epidemiological study conducted in Italy.
METHODS: Since 1997, a large cross sectional study has been conducting on the characteristics of women around menopause attending a network of first level outpatients menopause clinics in Italy for general counseling about menopause or treatment of menopausal symptoms. Eligible for the study were women consecutively observed at the participating centers. Up to March 2000, a total of 42464 women (mean age 53 years) were observed. Women were asked, using the same questionnaire, about their general characteristics and habits, and if they suffer of OA diagnosed by a physician requiring medical or surgical treatment.
RESULTS: A total of 12521 women reported OA. The risk of OA increased with body mass index (BMI), the odds ratio, OR, being for BMI>or equal to 27 versus <24, 1.56 (95%CI 1.47-1.64). The risk increased with a history of osteoporosis/osteopenia (OR 1.65, 95%CI 1.57-1.74) and was lower in more educated women (OR high school/university degree vs. primary school degree 0.79, 95%CI 0.75-0.84). Considering menopausal status, women in spontaneous or surgical menopause were, at increased risk of OA (OR 1.13, 95%CI 1.07-1.21, and 1.18, 95%CI 1.08-1.28, respectively, in women in surgical and spontaneous menopause). No clear relationship, however, emerged with age at menopause. Ever hormonal replacement therapy users were at decreased risk of OA, the OR being for ever users in comparison with never 0.73 (95%CI 0.69-0.78).
CONCLUSION: This analysis gives some epidemiological support to the hypothesis that estrogen deficiency may increased the risk of OA.

Entities:  

Mesh:

Year:  2003        PMID: 14585523     DOI: 10.1016/s0378-5122(03)00193-2

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  17 in total

1.  Serum concentrations of selected endogenous estrogen and estrogen metabolites in pre- and post-menopausal Chinese women with osteoarthritis.

Authors:  W Gao; C Zeng; D Cai; B Liu; Y Li; X Wen; Y Chen
Journal:  J Endocrinol Invest       Date:  2010-03-25       Impact factor: 4.256

2.  Association of osteoarthritis with serum levels of the environmental contaminants perfluorooctanoate and perfluorooctane sulfonate in a large Appalachian population.

Authors:  Kim E Innes; Alan M Ducatman; Michael I Luster; Anoop Shankar
Journal:  Am J Epidemiol       Date:  2011-06-27       Impact factor: 4.897

3.  Reproductive factors and risk of total knee replacement due to severe knee osteoarthritis in women, the Singapore Chinese Health Study.

Authors:  Y-Y Leung; M Talaei; L-W Ang; J-M Yuan; W-P Koh
Journal:  Osteoarthritis Cartilage       Date:  2019-03-19       Impact factor: 6.576

Review 4.  Menopause and Rheumatic Disease.

Authors:  Mitali Talsania; Robert Hal Scofield
Journal:  Rheum Dis Clin North Am       Date:  2017-05       Impact factor: 2.670

5.  Estrogen receptor Alpha in human knee articular cartilage of healthy and osteoarthritic females.

Authors:  Marissa L Hughbanks; Francisco Rodriguez-Fontan; Christopher J Kleck; Evalina Burger-Van der Walt
Journal:  J Orthop       Date:  2021-08-10

6.  Self-reported osteoarthritis, ethnicity, body mass index, and other associated risk factors in postmenopausal women-results from the Women's Health Initiative.

Authors:  Nicole C Wright; Gail Kershner Riggs; Jeffrey R Lisse; Zhao Chen
Journal:  J Am Geriatr Soc       Date:  2008-07-17       Impact factor: 5.562

7.  Tumor necrosis factor alpha (TNF-α) and estrogen hormone in osteoarthritic female patients.

Authors:  Pradeep Sharma; Neelima Singh; Vinod Singh; Sanjeev Singh; Harsh Vardhan Singh; Sameer Gupta
Journal:  Indian J Clin Biochem       Date:  2006-03

8.  Association between the interaction of SMAD3 polymorphisms with body mass index and osteoarthritis susceptibility.

Authors:  Baolin Kang; Feng Zhao; Xin Zhang; Xiao Deng; Xijing He
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

9.  Follicle stimulating hormone and estradiol alter immune response in osteoarthritic mice in an opposite manner.

Authors:  Lyudmila Belenska-Todorova; Ralitsa Zhivkova; Maya Markova; Nina Ivanovska
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

10.  Selective inhibition of progesterone receptor in osteochondral progenitor cells, but not in mature chondrocytes, modulated subchondral bone structures.

Authors:  Chenlin Dai; Junjing Jia; Alexander Kot; Xueping Liu; Lixian Liu; Min Jiang; Nancy E Lane; Barton L Wise; Wei Yao
Journal:  Bone       Date:  2019-12-19       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.